NL-OMON36731尚未招募不适用
Pilot study to investigate whether oral phosphorus binders can reduce FGF23 levels and can influence vascular function as measured by pulse wave velocity in patiens with chronic kidney disease stage 3 (eGFR 30-60 ml/min/1,73 m2). - Effect van fosfaat verlaging op FGF23 en bloedvaten
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1.patients with eGFR 30-60 ml/min/1,73 m2
- •2.serum phosphorus level <1,49 mmol/L and >0,9 mmol/L
- •3.age >18 year
- •4.informed consent
排除标准
- •1. known allergy or intolerance for sevelamer-containing drugs
- •2. patients with heart failure
- •3. Use of phosphate binder therapy
- •4. Patients dependent on tube-feeding or those with malabsorption syndrome
- •5. rapidly deteriorating renal function
- •6. pregnant woman
- •7 patient with kidney transplantation
研究者
相似试验
招募中
不适用
Effect van fosfaat verlaging op FGF23 en bloedvaten.Effect of phosphate reduction on FGF23 and bloodvessel function.NL-OMON25966Vrije Universiteit Medisch Centrum (VUmc) Amsterdam20
已完成
不适用
Clinical study to elucidate the efficacy of oral propranolol treatment for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000012123Juntendo University School of Medicine150
进行中（未招募）
不适用
Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature. Study PRENECAincidence of nephrocalcinosis in extremely preterm infantsMedDRA version: 14.1Level: PTClassification code 10029146Term: NephrocalcinosisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2012-000298-22-ESFundació Clínic per a la Recerca Biomèdica
招募中
Unknown
A clinical study to evaluate the effect of oral appliance on sleep apnea syndromeobstractive sleep apneaJPRN-UMIN000049236Tohoku University Graduate School of Dentistry45
尚未招募
2 期
Ayurvedic therapy for the children with autistic features.CTRI/2021/12/038901All India Institute of Ayurveda